Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

FEI announces changes to Equine Prohibited Substances List
FEI Bureau has approved the changes proposed by the FEI List Group

The Fédération Equestre Internationale (FEI) Bureau has approved changes to the Equine Prohibited Substances List proposed by its List Group. The new prohibited substances list will come into effect on January 1, 2014.

Previously unlisted Metformin, a potent but legitimate oral anti-diabetic drug with a potential welfare risk, has been added to the Controlled Medication list.

Levothyroxine, an exogenous thyroid hormone replacement that could enhance performance, has also been added to the Controlled Medication list after having been unlisted.

Adrenocortico-trophic hormone (ACTH) will be moved from Banned Substances to the Controlled Medication section for the 2014 list, due to its therapeutic value in equine medicine.

Three previously unlisted substances will be added to the Banned Substances section of the 2014 list .

Ammonium Chloride injectable, Gamma Butyrolactone (GBL) and Gamma-Hydroxybutyrate (GHB) are considered to have the potential for abuse to improve athletic performance.

The approved changes to the list are also accessible on the FEI Clean Sport webpage.

The FEI Equine Prohibited Substances Database will be amended and the complete 2014 list will be made available on the Clean Sport website prior to January 1, 2014.

Conforming with FEI rules, all changes to the list are published 90 days prior to implementation to allow National Federations, athletes and veterinarians sufficient time to familiarise themselves with the revised list.

 

Become a member or log in to add this story to your CPD history

FIVP launches CMA remedies survey

News Story 1
 FIVP has shared a survey, inviting those working in independent practice to share their views on the CMA's proposed remedies.

The Impact Assessment will help inform the group's response to the CMA, as it prepares to submit further evidence to the Inquiry Group. FIVP will also be attending a hearing in November.

Data will be anonymised and used solely for FIVP's response to the CMA. The survey will close on Friday, 31 October 2025. 

Click here for more...
News Shorts
CMA to host webinar exploring provisional decisions

The Competition and Markets Authority (CMA) is to host a webinar for veterinary professionals to explain the details of its provisional decisions, released on 15 October 2025.

The webinar will take place on Wednesday, 29 October 2025 from 1.00pm to 2.00pm.

Officials will discuss the changes which those in practice may need to make if the provisional remedies go ahead. They will also share what happens next with the investigation.

The CMA will be answering questions from the main parties of the investigation, as well as other questions submitted ahead of the webinar.

Attendees can register here before Wednesday, 29 October at 11am. Questions must be submitted before 10am on 27 October.

A recording of the webinar will be accessible after the event.